A Comparative Clinical Study to Evaluate the Therapeutic Efficacy of Different Modalities of Ruksha Pinda Sweda in the Management of Amavata W.S.R Rheumatoid Arthritis.
试验速览
- 阶段
- Phase 3 4
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- VAS scale, 2010 ACR EULAR classification criteria for Rheumatoid Arthritis, ROM by Goniometer
研究概览
简要总结
Amavata, as described in Ayurveda, is a condition resulting from factors like an incompatible diet, weak digestion, and a sedentary lifestyle, exacerbated by indulgence in unctuous foods and exercise. Ama, a product of incomplete metabolism, accumulates in the body and is driven by vitiated Vata to affect various areas, leading to symptoms like body pain, loss of appetite, fatigue, and joint-related issues. Rheumatoid Arthritis (RA) is a systemic autoimmune disease primarily impacting joints, causing symmetrical arthritis, cartilage and bone damage. It affects approximately 1% of the world’s population, with a higher prevalence in women. Management is complex, involving medication, dietary control, and lifestyle changes, but internal medications may not always provide optimal results. In Ayurveda, Amavata is treated with therapeutic techniques like Swedana, Langhana, and herbal preparations like Tikta-Katu Deepana. Swedana, which uses specific heated medicines, enhances metabolic activity, a key aspect of Amavata management. Ruksha Pinda Sweda, involving dry heated boluses, is commonly used, with Valuka Sweda as an ancillary treatment. A comparative study explores alternative therapies like Karisha and Ayas Pinda Sweda’s efficacy for Amavata. Both systems, Ayurveda and modern medicine, address joint-related conditions, offering holistic and integrated approaches to improve the quality of life for those affected.
研究设计
- 研究类型
- Interventional
- 分配方式
- Random Number Table
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients fulfilling diagnostic criteria.
- •Participants satisfying 2010 ACR EULAR classification criteria for rheumatoid arthritis.
- •Patients having a clinical presentation of Amavata.
排除标准
- •Patients with major systemic illnesses like cardiac disease, uncontrolled hypertension, kidney disease, and uncontrolled diabetes mellitus.
- •Those who have undergone surgical treatment in affected joints.
- •Patients who report any untoward symptoms during the period of study.
结局指标
主要结局
VAS scale, 2010 ACR EULAR classification criteria for Rheumatoid Arthritis, ROM by Goniometer
时间窗: 1,7 & 14 Day
次要结局
- Anthropometric measurement of big joints by measuring tape & Jeweler’s ring sizer(measurement for small joints.)
